Oppenheimer Reaffirms Their Buy Rating on Biogen (BIIB)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Olson is a 3-star analyst with an average return of 2.8% and a 37.73% success rate. Olson covers the Healthcare sector, focusing on stocks such as Biogen, Ionis Pharmaceuticals, and Neurocrine.
In addition to Oppenheimer, Biogen also received a Buy from TD Cowen's Phil Nadeau in a report issued today. However, on the same day, Needham maintained a Hold rating on Biogen (NASDAQ: BIIB).
Based on Biogen's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.43 billion and a net profit of $240.5 million. In comparison, last year the company earned a revenue of $2.29 billion and had a net profit of $393.4 million
Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, Rachid Izzar, the Head of Global Product Strat of BIIB sold 2,223.00 shares for a total of $300,105.00.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
LINE Investors Have Opportunity to Lead Lineage, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Lineage, Inc. ('Lineage' or 'the Company') (NASDAQ: LINE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ('IPO') conducted in July 2024, are encouraged to contact the firm before September 30, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Lineage suffered a weakening of demand as customers destocked excessive inventory and adjusted their businesses to changing consumer trends. The Company raised prices leading up to the IPO in an unsustainable manner. The Company failed to counteract its demand problems through marketing or its supposed competitive advantages. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Lineage, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Business Insider
2 hours ago
- Business Insider
Archer Aviation Falls 14% as JPMorgan Lifts Price Target but Flags Cash Burn Before Earnings
Despite Archer Aviation's (ACHR) step-by-step build-up toward commercial flight, the stock remains in a pre-commercial, pre-revenue stage. As long as that remains true, its valuation will stay speculative. That makes the shares volatile, especially in periods of mixed sentiment or shifting momentum across the electric vertical take-off and landing space. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. This past week, shares of Archer Aviation fell 14.53% in the last five trading days, closing at $9.64 on August 1. The drop followed several sessions of steady selling, with no major news from the company itself. Trading volume remained light, while the put-call ratio climbed, signaling increased interest in downside protection. The company's second-quarter earnings are due on August 11. JPM Highlights Continued Cash Burn On the analyst front, JPMorgan's analyst Bill Peterson raised his price target on Archer Aviation from $9 to $10 but maintained a Neutral rating. The firm acknowledged recent momentum in the eVTOL sector but called it 'irrational exuberance.' While the Trump administration's latest executive order signals long-term government support for the category, Peterson does not expect it to change the company's earnings outlook in the near term. The firm highlighted continued cash burn and potential delays in revenue generation as key risks. Technically, the stock is sending mixed signals. The Moving Average Convergence Divergence (MACD) indicator suggests that Archer is a Buy. However, the 20-day and 50-day exponential moving averages suggest otherwise. Both are above the current price, indicating a short-term sell. Overall technical sentiment is neutral. With shares trading below both key moving averages and a cautious tone from one of the company's core covering analysts, investors appear to be recalibrating their near-term expectations. Is Archer Aviation Stock a Good Buy? an average 12-month price target of $11.92. This implies a 23.65% upside from the current price.
Yahoo
2 hours ago
- Yahoo
I think Nvidia stock is now either very expensive
Sometimes, a really interesting opportunity comes along in the stock market. Take Nvidia (NASDAQ: NVDA) as an example. Having soared 1,576% in five years and recently become the first $4trn listed company ever, I would hardly say Nvidia stock is flying under investors' radar. But its price is pretty interesting, in my view. From a long-term perspective, I am not confident that Nvidia today is reasonably priced. I think it may turn out to be either very overpriced – or selling for a song. The one big question for Nvidia That is because I reckon Nvidia's valuation down the line ultimately hinges on one key question: how big will the future market for AI-related chips be? In my view, if it is as big as today or bigger and Nvidia maintains its dominant position, the current Nvidia stock price could be a bargain. But if that total market size shrinks, I think Nvidia is badly overvalued. You will notice I am focusing mostly on market size here. That is because I reckon Nvidia has a strong chance of maintaining or growing its market share over time. Barriers to entry are high. Nvidia has a talented workforce, proprietary technology, a large installed user base, and a proven business model. That could change, especially over time. Competitors may prove to be more nimble, or outsmart Nvidia when it comes to chip design. But I think it is credible to think that Nvidia will maintain a powerful market position. Its economies of scale and pricing power already make it massively profitable. If it can grow sales volumes, its profit margins could get even fatter thanks to greater economies of scale. That could help propel the Nvidia stock price far above today's level — if it happens. Everything to play for It may not happen, of course. Sometimes a key technology comes along and sparks a sales boom, only for it to later fall in popularity or become obsolete. If all those companies paying top dollar for Nvidia chips decide they already have enough from their initial installation, or land on an alternative technological solution for their AI dreams, the market could collapse. Personally I do not expect that to happen, but it could do. The sort of spending we have seen in the past couple of years from large tech companies seems hard if not impossible to sustain over the long term in the absence of transformational business results, I reckon. There is also a risk that Nvidia could lose market share regardless of what happens to the market size. While I see its position as fairly secure for now – in the absence of curveballs like export bans – over time I have less confidence. Plenty of rivals would be thrilled if they could eat Nvidia's breakfast and the more time they have, the more likely it is that at least one of them will figure out how to do it. The risk of a demand collapse puts me off buying Nvidia stock at its current price. But I would be surprised if the price is the same five years from now. I think it is most likely to be markedly higher – or a lot lower. The post I think Nvidia stock is now either very expensive – or very cheap appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Nvidia. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Sign in to access your portfolio
